Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
Part of paid clinical trials in York, Pennsylvania.
- Sponsor
- WellSpan Health
- Study ID
- NCT04570553
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- surgical staging — PROCEDUREPatients will undergo standard surgical staging for endometrial cancer utilizing either a V-care uterine manipulator or sponge stick
Study Details
This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
Key Dates
- Start date
- Oct 15, 2020
- Status verified
- Apr 2024
- Primary completion
- Apr 30, 2026
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 350 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- DIAGNOSTIC
Arms
- Experimental: V-care uterine manipulatorPatients in the V-care uterine manipulator arm will undergo standard staging surgery utilizing a V-care uterine manipulator in the standard fashion
- Active Comparator: Sponge stickPatients in the sponge stick arm will undergo standard staging surgery utilizing a non-invasive sponge stick for cervical delineation.
Primary Outcome Measure
Conversion of positive peritoneal cytology [ Time Frame: 2 years ]
Central Contacts
- Graham Brown, DO717-851-6120
- Eav Lim, DO717-851-6120
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Wellspan Health | York | Pennsylvania | 17403 |
Find similar trials in York, PA
By condition
By specialty
By research site
Related Studies
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruiting · Massive Bio, Inc. · Birmingham, Alabama
- A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPHASE1/PHASE2 · Recruiting · Novartis Pharmaceuticals · Atlanta, Georgia
- Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their DiseaseRecruiting · Memorial Sloan Kettering Cancer Center · Hartford, Connecticut
- A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPHASE1/PHASE2 · Recruiting · Alliance Foundation Trials, LLC. · Duarte, California